Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Gross Profit (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Gross Profit for 16 consecutive years, with $34.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Gross Profit fell 10.81% to $34.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $169.9 million, a 12.61% increase, with the full-year FY2025 number at $178.5 million, up 18.32% from a year prior.
  • Gross Profit was $34.4 million for Q4 2025 at Lemaitre Vascular, down from $49.1 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $49.1 million in Q3 2025 to a low of $23.8 million in Q1 2021.
  • A 5-year average of $32.7 million and a median of $31.5 million in 2023 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: soared 57.15% in 2021, then decreased 10.81% in 2025.
  • Lemaitre Vascular's Gross Profit stood at $26.0 million in 2021, then increased by 0.38% to $26.1 million in 2022, then rose by 27.68% to $33.3 million in 2023, then increased by 16.01% to $38.6 million in 2024, then fell by 10.81% to $34.4 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Gross Profit are $34.4 million (Q4 2025), $49.1 million (Q3 2025), and $45.0 million (Q2 2025).